AffiAB® Anti-Hu CD38 FITC [HIT2]

https://www.affiab.com/web/image/product.template/109879/image_1920?unique=d31c23b
(0 review)

CAT# AFG-EXB-1211
Size: 100 Tests

239.00 239.0 USD 239.00

239.00

For Price Contact info@affigen.com

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Overview

CD38 (NAD+ glycohydrolase) is a type II transmembrane glycoprotein able to induce activation, proliferation and differentiation of mature lymphocytes and mediate apoptosis of myeloid and lymphoid progenitor cells. Another role of CD38 is provided by enzymatic activity of its extracellular part. CD38 acts as NAD+ glycohydrolase converting NAD+ into ADP-ribose, as ADP-ribosyl cyclase producing cADPR and as cADPR hydrolase, thus affecting levels of calcium-mobilizing metabolites. ADPR produced by CD38 serves as an important second messenger of neutrophil and dendritic cell migration.


Specificity:

The mouse monoclonal antibody HIT2 reacts with an extracellular epitope of CD38, a 45 kDa type II transmembrane glycoprotein strongly expressed mainly on plasma cells and activated T and B lymphocytes; it is an antigenic marker of lymphoid cells. Its binding is blocked by daratumumab.

Antigen

CD38

Clone

HIT2

Species Reactivity

Human

Negative Species

N/A

Isotype

Mouse IgG1

Immunogen

Human thymocytes in foetus

Application

FC (QC tested)

Regulatory status

RUO

Concentration

N/A

Format

FITC

Storage / Stability

Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.

Storage Buffer

Stabilizing phosphate buffered saline (PBS) , pH 7.4, 15 mM sodium azide